Volume 31, Number 5—May 2025
Synopsis
Comprehensive Survival Analysis of Alveolar Echinococcosis Patients, University Hospital Zurich, Zurich, Switzerland, 1973–2022
Ansgar Deibel1
, Yanick Kindler1, Rubens Mita, Soleen Ghafoor, Cordula Meyer zu Schwabedissen, Barbara Brunner-Geissmann, Alexander Schweiger, Felix Grimm, Michael Reinehr, Achim Weber, Cäcilia S. Reiner, Andreas E. Kremer, Henrik Petrowsky, Pierre-Alain Clavien, Peter Deplazes, Stefanie von Felten, and Beat Müllhaupt
, Yanick Kindler1, Rubens Mita, Soleen Ghafoor, Cordula Meyer zu Schwabedissen, Barbara Brunner-Geissmann, Alexander Schweiger, Felix Grimm, Michael Reinehr, Achim Weber, Cäcilia S. Reiner, Andreas E. Kremer, Henrik Petrowsky, Pierre-Alain Clavien, Peter Deplazes, Stefanie von Felten, and Beat Müllhaupt
Table 3
Characteristics of patients who died because of AE, University Hospital Zurich, Zurich, Switzerland, 1973–2022*
| ID | Year diag | Age, y/sex | Stage | Symp | Comp | Surgery | Time to surgery, mo† | Aim | BMZ | Time to BMZ† | Survival time, mo† | Direct cause of death |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
1973 |
26/M |
IV |
Yes |
None |
Yes |
37 |
Palliative, with biliodigestive anastomosis |
Yes‡ |
94 |
384 |
Biliocutaneous fistula, recurrent biliary infections, secondary biliary cirrhosis |
| 2 |
1975 |
57/M |
IV |
Yes |
Vascular |
Yes |
0 |
Curative |
Yes |
80 |
238 |
Retroperitoneal recurrence, total IVC occlusion, GI hemorrhage |
| 3 |
1975 |
54/F |
IV |
Yes |
None |
NA |
NA |
NA |
Yes |
77 |
104 |
Cerebral AE manifestation |
| 4 |
1978 |
68/F |
II |
Yes |
Biliary |
Yes |
0 |
Palliative, with biliodigestive anastomosis |
Yes |
0 |
35 |
Recurrent biliary infections, secondary biliary cirrhosis |
| 5 |
1979 |
44/F |
IIIa |
Yes |
Vascular |
NA |
NA |
NA |
Yes |
0 |
281 |
ERCP for pancreatitis, decompensation, peritonitis |
| 6 |
1980 |
61/F |
IV |
Yes |
Biliary |
NA |
NA |
NA |
Yes |
0 |
133 |
Secondary biliary cirrhosis |
| 7 |
1982 |
67/M |
IV |
Yes |
Vascular |
NA |
NA |
NA |
Yes |
0 |
159 |
Variceal bleeding |
| 8 |
1983 |
64/F |
IIIb |
Yes |
Biliary |
NA |
NA |
NA |
Yes |
0 |
53 |
Cholangitis with liver abscess |
| 9 |
1983 |
47/F |
II |
Yes |
None |
Yes |
0 |
Palliative |
Yes |
0 |
233 |
Progressive disease, secondary surgery, postoperative multiorgan failure |
| 10 |
1988 |
67/M |
IIIa |
Yes |
Biliary |
Yes |
0 |
Palliative |
Yes |
1 |
149 |
PTCD for cholangitis |
| 11 |
2001 |
48/M |
IV |
Yes |
None |
Yes |
0 |
Palliative, nonhepatic |
Yes |
0 |
193 |
Cerebral AE manifestation |
| 12 |
2001 |
56/F |
IIIb |
Yes |
Vascular |
NA |
NA |
NA |
Yes |
0 |
187 |
Liver failure because of portal and liver vein thrombosis |
| 13 | 2017 | 60/F | IV | Yes | Biliary | NA | NA | NA | Yes | 0 | 70 | PTCD for cyst infection with rupture and peritoneal dissemination |
*AE, alveolar echinococcosis; BMZ, benzimidazole drug therapy; comp, complications at diagnosis; diag, diagnosed; ERCP, endoscopic retrograde cholangiopancreaticography; ID, identification number; IVC, inferior vena cava; PTCD, percutaneous transhepatic cholangiography and drainage; symp, symptoms at diagnosis; surg, surgery. †Time after diagnosis. ‡Discontinued after 195 months because of intolerance (95 months before death).
1These first authors contributed equally to this article.
Page created: March 11, 2025
Page updated: May 05, 2025
Page reviewed: May 05, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.